Ignatowska-Jankowska, Bogna M.Baillie, Gemma L.Kinsey, StevenCrowe, MollyGhosh, SudeshnaOwens, Robert A.Damaj, Imad M.Poklis, JustinWiley, Jenny L.Zanda, MatteoZanato, ChiaraGreig, Iain R.Lichtman, Aron H.Ross, Ruth A.2016-05-312016-05-312015-12Ignatowska-Jankowska, B M, Baillie, G L, Kinsey, S, Crowe, M, Ghosh, S, Owens, R A, Damaj, I M, Poklis, J, Wiley, J L, Zanda, M, Zanato, C, Greig, I R, Lichtman, A H & Ross, R A 2015, 'A Cannabinoid CB 1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects', Neuropsychopharmacology, vol. 40, pp. 2948-2959. https://doi.org/10.1038/npp.2015.1480893-133XORCID: /0000-0003-0603-3383/work/65549942http://hdl.handle.net/2164/604112396375engSDG 3 - Good Health and Well-beingcell signallingdrug therapyneuropathic painRC0321 Neuroscience. Biological psychiatry. NeuropsychiatryPharmacologyPsychiatry and Mental healthRC0321A Cannabinoid CB 1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive EffectsJournal article10.1038/npp.2015.148https://www.scopus.com/pages/publications/84947026298https://rdcu.be/cfvgb